Anti-Human Integrin alpha 5 beta 1 Therapeutic Antibody (Volociximab)
Recombinant monoclonal antibody to Integrin Integrin alpha 5 beta 1. Volociximab (also known as M200) is a chimeric monoclonal antibody jointly for treatment of a variety of advanced solid tumors. It binds to and inhibits the functional activity of α5β1 integrin.
It is thought to reduce metastases. Early results show potential in renal cell cancers.
It is thought to reduce metastases. Early results show potential in renal cell cancers.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-077 |
| Pricing | Inquiry |
| Host | Mouse |
| Target | Integrin alpha 5 beta 1 |
| Species Reactivity | Human |
| Type | IgG4 |
| Applications | ELISA, IHC |
| Storage | Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples. |